Progression of chronic obstructive pulmonary disease: impact of inflammation, comorbidities and therapeutic intervention
- 1 April 2009
- journal article
- review article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 25 (5) , 1235-1245
Abstract
(2009). Progression of chronic obstructive pulmonary disease: impact of inflammation, comorbidities and therapeutic intervention. Current Medical Research and Opinion: Vol. 25, No. 5, pp. 1235-1245. doi: 10.1185/03007990902868971Keywords
This publication has 104 references indexed in Scilit:
- Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease: Results from the TORCH StudyAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trialThorax, 2007
- Systemic Effects of SmokingChest, 2007
- Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint CommitteeThorax, 2007
- Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysisThorax, 2006
- C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary diseaseThorax, 2006
- Inflammatory cells in the airways in COPDThorax, 2006
- Corticosteroids and adrenoceptor agonists: The compliments for combination therapy in chronic airways diseasesEuropean Journal of Pharmacology, 2006
- Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPDEuropean Respiratory Journal, 2004
- Alveolar Macrophages as Orchestrators of COPDCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2004